|
US2086186A
(en)
*
|
1933-10-10 |
1937-07-06 |
Us Rubber Co |
Treatment of rubber
|
|
SU50906A1
(ru)
|
1935-12-20 |
1936-11-30 |
А.И. Бурляев |
Веретено дл пр дильных машин
|
|
GB1435721A
(en)
|
1972-05-18 |
1976-05-12 |
Lilly Industries Ltd |
Benzoxazole derivatives
|
|
SU509046A1
(ru)
*
|
1975-02-21 |
1984-06-23 |
Всесоюзный научно-исследовательский химико-фармацевтический институт им.Серго Орджоникидзе |
Производные 2-карбэтокси-3-аминоиндола,про вл ющие противовоспалительную активность, и способ их получени
|
|
JPS6192592A
(ja)
|
1984-10-12 |
1986-05-10 |
Norin Suisansyo Shokuhin Sogo Kenkyusho |
分岐サイクロデキストリンの製造方法
|
|
US4675332A
(en)
|
1984-12-10 |
1987-06-23 |
Warner-Lambert Company |
Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents
|
|
GB8610981D0
(en)
|
1986-05-06 |
1986-06-11 |
Ici America Inc |
Quinoline amides
|
|
NZ225045A
(en)
|
1987-07-01 |
1990-06-26 |
Janssen Pharmaceutica Nv |
Antiviral pharmaceutical compositions containing cyclodextrin and an antiviral agent
|
|
US5002935A
(en)
|
1987-12-30 |
1991-03-26 |
University Of Florida |
Improvements in redox systems for brain-targeted drug delivery
|
|
US5376645A
(en)
|
1990-01-23 |
1994-12-27 |
University Of Kansas |
Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
|
|
CA2072001C
(en)
|
1990-10-22 |
1998-11-03 |
Nimai C. De |
Method and composition for cleaning contact lenses
|
|
CA2054339C
(en)
*
|
1990-11-02 |
2002-12-24 |
Francesco G. Salituro |
3-amidoindolyl derivatives
|
|
US5668117A
(en)
|
1991-02-22 |
1997-09-16 |
Shapiro; Howard K. |
Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
|
|
US6444221B1
(en)
|
1992-06-30 |
2002-09-03 |
Howard K. Shapiro |
Methods of treating chronic inflammatory diseases using carbonyl trapping agents
|
|
US20050090553A1
(en)
|
1992-06-30 |
2005-04-28 |
Shapiro Howard K. |
Compositions and method for treatment of chronic inflammatory diseases
|
|
US5472954A
(en)
|
1992-07-14 |
1995-12-05 |
Cyclops H.F. |
Cyclodextrin complexation
|
|
TW401300B
(en)
|
1992-12-25 |
2000-08-11 |
Senju Pharma Co |
Antiallergic composition for ophthalmic or nasal use
|
|
US5493027A
(en)
|
1993-01-22 |
1996-02-20 |
Board Of Regents, The University Of Texas System |
Anticonvulsive agents and uses thereof
|
|
JP2746832B2
(ja)
|
1993-05-14 |
1998-05-06 |
大鵬薬品工業株式会社 |
眼局所抗アレルギー剤
|
|
GB9318431D0
(en)
|
1993-09-06 |
1993-10-20 |
Boots Co Plc |
Therapeutic agents
|
|
US5767109A
(en)
|
1993-10-20 |
1998-06-16 |
Sanchez; Robert A. |
Complexing urushiols
|
|
US5576311A
(en)
|
1994-11-30 |
1996-11-19 |
Pharmos Corporation |
Cyclodextrins as suspending agents for pharmaceutical suspensions
|
|
JP3297969B2
(ja)
|
1994-12-26 |
2002-07-02 |
ライオン株式会社 |
点眼剤
|
|
US5597823A
(en)
|
1995-01-27 |
1997-01-28 |
Abbott Laboratories |
Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists
|
|
US5625068A
(en)
*
|
1995-06-05 |
1997-04-29 |
American Cyanamid Company |
Substituted quinoline herbicide intermediates and process
|
|
FR2742053B1
(fr)
|
1995-12-06 |
1998-03-06 |
Chauvin Lab Sa |
Compositions pharmaceutiques a base de mequitazine
|
|
JP3736916B2
(ja)
|
1996-02-19 |
2006-01-18 |
株式会社サンコンタクトレンズ |
含水性ソフトコンタクトレンズの消毒用組成物とその用途
|
|
US6107300A
(en)
|
1996-03-27 |
2000-08-22 |
Dupont Pharmaceuticals |
Arylamino fused pyrimidines
|
|
KR20000029694A
(ko)
|
1996-08-01 |
2000-05-25 |
케네쓰 엘. 로에르트셔 |
살진균활성을갖는4-치환된퀴놀린유도체
|
|
SK14099A3
(en)
|
1996-08-06 |
2000-05-16 |
Pfizer |
Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
|
|
US6191127B1
(en)
*
|
1997-05-02 |
2001-02-20 |
Schering Aktiengesellschaft |
Substituted heterocycles and their use in medicaments
|
|
GB2327672A
(en)
*
|
1997-07-23 |
1999-02-03 |
Merck & Co Inc |
4-(1,2,3,4-Tetrahydro-1,8-naphthyridin-7-yl)butanoyl-glycyl-3(S)-quinolin-3-yl-beta-alanine
|
|
ATE221886T1
(de)
|
1997-09-02 |
2002-08-15 |
Bristol Myers Squibb Pharma Co |
Heterocyclyl-substituierte annellierte pyridine und pyrimidine als antagonisten des corticotropin freisetzenden hormons (crh), verwendbar für die behandlung von cns und stress
|
|
KR20010041811A
(ko)
*
|
1998-03-12 |
2001-05-25 |
온토젠 코포레이션 |
단백질 티로신 포스파타제의 조절제
|
|
US6498154B1
(en)
*
|
1999-05-04 |
2002-12-24 |
Wyeth |
Cyclic regimens using quinazolinone and benzoxazine derivatives
|
|
US6358948B1
(en)
|
1999-05-04 |
2002-03-19 |
American Home Products Corporation |
Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
|
|
JP3568108B2
(ja)
|
1999-07-28 |
2004-09-22 |
松下電器産業株式会社 |
デジタル地図の位置情報伝達方法とそれを実施する装置
|
|
US6515010B1
(en)
|
1999-11-15 |
2003-02-04 |
Smithkline Beecham Corporation |
Carvedilol methanesulfonate
|
|
AU1735001A
(en)
|
1999-12-10 |
2001-06-18 |
Senju Pharmaceutical Co., Ltd. |
Cyclodextrin-containing pharmaceutical composition
|
|
US6569879B2
(en)
|
2000-02-18 |
2003-05-27 |
Merck & Co., Inc. |
Aryloxyacetic acids for diabetes and lipid disorders
|
|
JP4748289B2
(ja)
|
2000-06-23 |
2011-08-17 |
ライオン株式会社 |
点眼剤、眼科用組成物及び吸着抑制方法
|
|
FR2827599A1
(fr)
|
2001-07-20 |
2003-01-24 |
Neuro3D |
Composes derives de quinoleine et quinoxaline,preparation et utilisations
|
|
UA83620C2
(ru)
|
2001-12-05 |
2008-08-11 |
Уайт |
Замещенные бензоксазолы и их аналоги как эстрогенные агенты
|
|
US20060014786A1
(en)
|
2002-05-17 |
2006-01-19 |
Rajeev Raut |
Opthalmic pharmaceutical compositions and methods for treating ocular inflammation
|
|
CA2451267A1
(en)
|
2002-12-13 |
2004-06-13 |
Warner-Lambert Company Llc |
Pharmaceutical uses for alpha2delta ligands
|
|
WO2004069157A2
(en)
|
2003-01-17 |
2004-08-19 |
Ophthalmic Research Associates, Inc. |
Combinational use of long-acting and short-acting anti-histamines for ocular allergies
|
|
US20040242704A1
(en)
|
2003-03-14 |
2004-12-02 |
University Of Washington, Techtransfer - Invention Licensing |
Stabilized mutant opsin proteins
|
|
EP2305308A1
(en)
|
2003-04-18 |
2011-04-06 |
Advanced Medicine Research Institute |
Remedies for diseases to be applied to eye
|
|
US20060111318A1
(en)
|
2003-04-18 |
2006-05-25 |
Advanced Medicine Research Institute |
Agent for treating eye diseases
|
|
US7297709B2
(en)
|
2003-05-22 |
2007-11-20 |
Abbott Laboratories |
Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
|
|
US20040235892A1
(en)
|
2003-05-22 |
2004-11-25 |
Yujia Dai |
Indazole and benzisoxazole kinase inhibitors
|
|
US7083803B2
(en)
|
2003-09-19 |
2006-08-01 |
Advanced Ocular Systems Limited |
Ocular solutions
|
|
JP2005132834A
(ja)
|
2003-10-09 |
2005-05-26 |
Kyowa Hakko Kogyo Co Ltd |
キノリン誘導体
|
|
EP2468729B1
(en)
*
|
2003-10-15 |
2013-12-25 |
Ube Industries, Ltd. |
Novel indazole derivative
|
|
EP1678160A1
(en)
|
2003-10-27 |
2006-07-12 |
Astellas Pharma Inc. |
Pyrazine derivatives and pharmaceutical use thereof
|
|
CN100558360C
(zh)
|
2003-11-20 |
2009-11-11 |
奥特拉控股公司 |
羟胺组合物在制备缓解黄斑变性和其他眼科疾病的药物中的用途
|
|
JP2005187407A
(ja)
|
2003-12-25 |
2005-07-14 |
Lion Corp |
アレルギー眼疾患用眼科組成物
|
|
US20050197292A1
(en)
|
2004-01-30 |
2005-09-08 |
Glennda Smithson |
Compositions and methods for treating T-cell mediated pathological conditions
|
|
RU2006133300A
(ru)
|
2004-02-17 |
2008-03-27 |
Президент Энд Феллоуз Оф Гарвард Колледж (Us) |
Управление течением офтальмологических расстройств, включая дегенерацию желтого пятна
|
|
US20050234018A1
(en)
|
2004-04-15 |
2005-10-20 |
Allergan, Inc. |
Drug delivery to the back of the eye
|
|
JP2006008568A
(ja)
|
2004-06-24 |
2006-01-12 |
Cyclochem:Kk |
ＩｇＥ抗体抑制剤および食品
|
|
WO2006002473A1
(en)
|
2004-07-02 |
2006-01-12 |
Adelaide Research & Innovation Pty Ltd |
Method of controlling damage mediated by alpha, beta-unsaturated aldehydes
|
|
FR2875409B1
(fr)
|
2004-09-17 |
2010-05-07 |
Sanofi Aventis |
Composition pharmaceutique comprenant une dispersion solide a matrice polymere comprenant une phase continue de polydextrose et une phase continue d'un polymere autre que du polydextrose
|
|
AU2005302608A1
(en)
|
2004-10-28 |
2006-05-11 |
Merck & Co., Inc. |
Pyrimidine and quinoline potentiators of metabotropic glutamate receptors
|
|
JPWO2006077821A1
(ja)
*
|
2005-01-19 |
2008-06-19 |
大日本住友製薬株式会社 |
アルドステロン受容体調節剤としての芳香族スルホン化合物
|
|
TW200640443A
(en)
|
2005-02-23 |
2006-12-01 |
Alcon Inc |
Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective RTK inhibitors
|
|
WO2006122183A2
(en)
|
2005-05-10 |
2006-11-16 |
Cytophil, Inc. |
Injectable hydrogels and methods of making and using same
|
|
PT1888548E
(pt)
|
2005-05-26 |
2012-10-30 |
Neuron Systems Inc |
Derivado de quinolina para o tratamento de doenças da retina
|
|
US8435965B2
(en)
|
2005-12-27 |
2013-05-07 |
Lion Corporation |
Composition for soft contact lens and adsorption suppressing method
|
|
US7842312B2
(en)
|
2005-12-29 |
2010-11-30 |
Cordis Corporation |
Polymeric compositions comprising therapeutic agents in crystalline phases, and methods of forming the same
|
|
US20070297981A1
(en)
|
2006-01-25 |
2007-12-27 |
Ousler George W Iii |
Formulations and methods for treating dry eye
|
|
JP4466875B2
(ja)
|
2006-04-05 |
2010-05-26 |
ライオン株式会社 |
ソフトコンタクトレンズ用点眼剤
|
|
NZ572591A
(en)
|
2006-04-14 |
2012-01-12 |
Prana Biotechnology Ltd |
3N-substituted 8-hydroxy-quinazolin-4-ones
|
|
JP5194218B2
(ja)
|
2006-06-05 |
2013-05-08 |
株式会社メニコンネクト |
含水性コンタクトレンズの保存方法ならびに該保存方法により保存された含水性コンタクトレンズ
|
|
WO2008014602A1
(en)
|
2006-07-25 |
2008-02-07 |
Envivo Pharmaceuticals, Inc. |
Quinoline derivatives
|
|
WO2008021271A1
(en)
|
2006-08-14 |
2008-02-21 |
Schering Corporation |
Salts of 5 - ( l ( s ) -amino - 2 - hydroxyethyl ) -n- [ ( 2, 4 -difluorophenyl) -methyl] - 2 - [ 8 -methoxy - 2 - (trifluoromethyl) - 5 - quinoline] - 4 - oxazolecarboxamide
|
|
MX370905B
(es)
|
2006-08-31 |
2020-01-09 |
Adare Pharmaceuticals Inc |
Sistema de distribucion de farmacos, que comprenden soluciones solidas de farmacos debilmente basicos.
|
|
US8158609B1
(en)
|
2006-11-02 |
2012-04-17 |
Novartis Ag |
Use of cyclodextrins as an active ingredient for treating dry AMD and solubilizing drusen
|
|
US20080241256A1
(en)
|
2007-03-30 |
2008-10-02 |
Liisa Kuhn |
Targeted active agent delivery system based on calcium phosphate nanoparticles
|
|
WO2008157740A2
(en)
|
2007-06-20 |
2008-12-24 |
Ironwood Pharmaceuticals, Inc. |
Faah inhibitors
|
|
RU2541430C2
(ru)
|
2007-10-05 |
2015-02-10 |
Акусела Инк. |
Композиции и способы лечения нейродегенеративных заболеваний
|
|
CA2714530C
(en)
|
2008-02-11 |
2018-09-25 |
University Of Washington |
Methods for the treatment and prevention of age-related retinal dysfunction
|
|
AU2009282076A1
(en)
|
2008-08-12 |
2010-02-18 |
Sirtris Pharmaceuticals, Inc. |
Benzoxazoles, benzthiazoles and related analogs as sirtuin modulators
|
|
EP2340242A4
(en)
|
2008-10-22 |
2012-04-04 |
Acucela Inc |
COMPOUNDS FOR THE TREATMENT OF EYE DISEASES AND DRESSES
|
|
AU2009315735B2
(en)
|
2008-11-11 |
2013-01-10 |
Novartis Ag |
Salts of fingolimod
|
|
JP2012520880A
(ja)
|
2009-03-17 |
2012-09-10 |
アーシエックス セラピューティックス， インコーポレイテッド |
ケトチフェンの眼科用製剤および使用方法
|
|
WO2010133672A1
(en)
|
2009-05-20 |
2010-11-25 |
Clanotech Ab |
Derivatives of quinoline-3-carboxylic acid and their medical use
|
|
MX2011013061A
(es)
|
2009-06-05 |
2012-02-28 |
Aciex Therapeutics Inc |
Formulaciones oftalmicas de fluticasona y metodos de uso.
|
|
US20100331315A1
(en)
|
2009-06-18 |
2010-12-30 |
Mustapha Haddach |
Rhodanines and related heterocycles as kinase inhibitors
|
|
EP2477594A4
(en)
|
2009-07-15 |
2013-03-13 |
Univ Vanderbilt |
ISOKETAL CATCHER AND TREATMENT OF DISEASES WITH OXIDATIVE INJURY
|
|
TWI492769B
(zh)
|
2009-09-23 |
2015-07-21 |
Alcon Res Ltd |
可注射的水性眼用組成物及其使用之方法
|
|
CA2783699C
(en)
|
2009-12-08 |
2019-01-15 |
Case Western Reserve University |
Primary amine compounds for treating ocular disorders
|
|
JP5885670B2
(ja)
|
2009-12-11 |
2016-03-15 |
アルデイラ セラピューティクス， インコーポレイテッド |
黄斑変性の処置のための組成物および方法
|
|
WO2011078204A1
(ja)
|
2009-12-24 |
2011-06-30 |
浜理薬品工業株式会社 |
高脂血症の予防または治療剤、および抗疲労剤
|
|
US9504671B2
(en)
|
2010-02-26 |
2016-11-29 |
Xenon Pharmaceuticals Inc. |
Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
|
|
WO2011116066A1
(en)
|
2010-03-17 |
2011-09-22 |
Concert Pharmaceuticals, Inc. |
Derivatives of dimethylcurcumin
|
|
WO2012030938A1
(en)
|
2010-09-01 |
2012-03-08 |
Arena Pharmaceuticals, Inc. |
Salts of lorcaserin with optically active acids
|
|
US9718796B2
(en)
|
2011-01-12 |
2017-08-01 |
Ventirx Pharmaceuticals, Inc. |
Substituted benzoazepines as toll-like receptor modulators
|
|
US10463687B2
(en)
|
2011-01-20 |
2019-11-05 |
Cornell University |
Treatments for retinal disorders
|
|
WO2012105887A1
(en)
|
2011-01-31 |
2012-08-09 |
Tim Bowden |
Active principle for mitigating undesired medical conditions
|
|
TWI544922B
(zh)
|
2011-05-19 |
2016-08-11 |
愛爾康研究有限公司 |
高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
|
|
US20130190500A1
(en)
|
2011-12-12 |
2013-07-25 |
Neuron Systems, Inc. |
Process to prepare 6-chloro-3-amino-2-(2-hydroxypropyl)-1-azanaphthalene
|
|
US20130165419A1
(en)
|
2011-12-21 |
2013-06-27 |
Insite Vision Incorporated |
Combination anti-inflammatory ophthalmic compositions
|
|
GB201200192D0
(en)
|
2012-01-06 |
2012-02-22 |
Rosemont Pharmaceuticals Ltd |
Methotrexate composition
|
|
EP2879683B1
(en)
|
2012-08-01 |
2020-01-22 |
Lewis and Clark Pharmaceuticals, Inc. |
N-alkyl-alkynyladenosine-5-uronamide compounds as agonists of a2a receptor
|
|
ES3023054T3
(en)
|
2012-11-08 |
2025-05-29 |
Clearside Biomedical Inc |
Methods for the treatment of ocular disease in human subjects
|
|
CN105073714A
(zh)
|
2012-12-20 |
2015-11-18 |
奥尔德拉医疗公司 |
迫位原醇
|
|
JP6514114B2
(ja)
|
2013-01-23 |
2019-05-15 |
アルデイラ セラピューティクス， インコーポレイテッド |
毒性アルデヒド関連疾患および処置
|
|
AU2014209346B2
(en)
|
2013-01-23 |
2018-11-15 |
Semnur Pharmaceuticals, Inc. |
Pharmaceutical formulation comprising an insoluble corticosteroid and a soluble corticosteroid
|
|
KR20150120380A
(ko)
|
2013-01-25 |
2015-10-27 |
알데이라 테라퓨틱스, 아이엔씨. |
황반 변성의 치료에서 신규한 트랩
|
|
TWI643853B
(zh)
|
2013-02-27 |
2018-12-11 |
阿爾米雷爾有限公司 |
同時具有β2腎上腺素受體促效劑和M3毒蕈鹼受體拮抗劑活性之2-氨基-1-羥乙基-8-羥基喹啉-2(1H)-酮衍生物之鹽類
|
|
US9713330B1
(en)
|
2013-03-15 |
2017-07-25 |
Deuteria Agrochemicals, Llc |
Deuterium-enriched aldehydes
|
|
US20160151410A1
(en)
|
2013-07-02 |
2016-06-02 |
The Trustees Of Columbia University In The City Of New York |
Clearance of bioactive lipids from membrane structures by cyclodextrins
|
|
EP3151818A4
(en)
|
2014-06-04 |
2018-05-30 |
Case Western Reserve University |
Compositions and methods of treating diabetic retinopathy
|
|
JP6634034B2
(ja)
|
2014-06-25 |
2020-01-22 |
シネルジア・バイオ・サイエンシーズ・プライベイト・リミテッドＳｙｎｅｒｇｉａ Ｂｉｏ Ｓｃｉｅｎｃｅｓ Ｐｒｉｖａｔｅ Ｌｉｍｉｔｅｄ |
医薬水中油型ナノエマルジョン
|
|
NO2721710T3
(OSRAM)
|
2014-08-21 |
2018-03-31 |
|
|
|
JP2017527614A
(ja)
|
2014-09-02 |
2017-09-21 |
ブピンダー シン |
重水素化又は非重水素化分子及び医薬製剤
|
|
TW201628622A
(zh)
|
2014-11-17 |
2016-08-16 |
製藥公司 |
Tlr抑制劑與布魯頓氏(bruton's)酪胺酸激酶抑制劑之組合
|
|
WO2016085939A2
(en)
|
2014-11-24 |
2016-06-02 |
Case Western Reserve University |
Compounds and methods of treating ocular disorders
|
|
CN107531682B
(zh)
|
2015-04-15 |
2021-05-04 |
百济神州有限公司 |
B-raf激酶抑制剂的马来酸盐、其结晶形式、制备方法和用途
|
|
WO2017035077A1
(en)
|
2015-08-21 |
2017-03-02 |
Aldeyra Therapeutics, Inc. |
Deuterated compounds and uses thereof
|
|
KR20180073553A
(ko)
|
2015-08-21 |
2018-07-02 |
알데이라 테라퓨틱스, 아이엔씨. |
알데히드 접합체 및 이의 용도
|
|
CN116531400A
(zh)
|
2016-02-28 |
2023-08-04 |
奥尔德拉医疗公司 |
用环糊精治疗过敏性眼部病状
|
|
EP3454858A4
(en)
|
2016-05-09 |
2020-01-15 |
Aldeyra Therapeutics, Inc. |
COMBINATION TREATMENT OF FLAMMABLE CONDITIONS AND DISEASES OF THE EYE
|
|
WO2017214201A1
(en)
|
2016-06-06 |
2017-12-14 |
Thesan Pharmaceuticals, Inc. |
Formulations for substituted 3-pyrrolidines, compositions containing, and uses of, same
|
|
CN109640983A
(zh)
|
2016-08-22 |
2019-04-16 |
奥尔德拉医疗公司 |
醛捕获化合物和其用途
|
|
WO2018039197A1
(en)
|
2016-08-22 |
2018-03-01 |
Aldeyra Therapeutics, Inc. |
Aldehyde trapping compounds and methods of use thereof
|
|
BR112019006160A2
(pt)
|
2016-09-28 |
2019-06-18 |
Medicon Pharmaceuticals Inc |
composições e métodos para o tratamento das condições oftálmicas
|
|
US10927094B2
(en)
|
2016-10-05 |
2021-02-23 |
Mitobridge, Inc. |
Crystalline and salt forms of PPAR agonist compounds
|
|
AU2018234919A1
(en)
|
2017-03-16 |
2019-09-19 |
Aldeyra Therapeutics, Inc. |
Polymorphic compounds and uses thereof
|
|
EP3694500A4
(en)
|
2017-10-10 |
2021-06-30 |
Aldeyra Therapeutics, Inc. |
TREATMENT OF INFLAMMATORY DISORDERS
|
|
WO2020018498A1
(en)
|
2018-07-16 |
2020-01-23 |
Aldeyra Therapeutics, Inc. |
Cyclodextrin formulations
|
|
US20200038392A1
(en)
|
2018-08-03 |
2020-02-06 |
Aldeyra Therapeutics, Inc. |
Topical compositions and methods of preparation and use
|
|
US12006298B2
(en)
|
2018-08-06 |
2024-06-11 |
Aldeyra Therapeutics, Inc. |
Polymorphic compounds and uses thereof
|
|
WO2020068986A1
(en)
|
2018-09-25 |
2020-04-02 |
Aldeyra Therapeutics, Inc. |
Formulations for treatment of dry eye disease
|
|
JP2022503994A
(ja)
|
2018-10-02 |
2022-01-12 |
アルデイラ セラピューティクス， インコーポレイテッド |
コンタクトレンズ溶液およびキット
|
|
EP3890732A4
(en)
|
2018-12-05 |
2022-08-24 |
Aldeyra Therapeutics, Inc. |
INJECTABLE FORMULATIONS
|
|
JP7706758B2
(ja)
|
2019-03-26 |
2025-07-14 |
アルデイラ セラピューティクス， インコーポレイテッド |
眼科用製剤およびその使用
|
|
EP3962894A4
(en)
|
2019-05-02 |
2023-01-11 |
Aldeyra Therapeutics, Inc. |
POLYMORPHIC COMPOUNDS AND USES THEREOF
|
|
US12098132B2
(en)
|
2019-05-02 |
2024-09-24 |
Aldeyra Therapeutics, Inc. |
Process for preparation of aldehyde scavenger and intermediates
|
|
US20230131929A1
(en)
|
2020-03-24 |
2023-04-27 |
Aldeyra Therapeutics, Inc. |
Quinoline compounds for treating respiratory disorders and viral infections
|
|
EP4149470A4
(en)
|
2020-05-13 |
2024-04-24 |
Aldeyra Therapeutics, Inc. |
Pharmaceutical formulations and uses thereof
|
|
US20230228744A1
(en)
|
2020-06-04 |
2023-07-20 |
Aldeyra Therapeutics, Inc. |
Dry eye disease biomarkers and their use for treatment
|